Abstract
In an increasing number of central nervous system (CNS) diseases a pathogenic contribution of the immune system is proposed. However, the exact underlying mechanisms are often poorly understood. The collection of articles in this special issue presents a state-of-the-art review of adaptive and innate immune mechanisms and their main players in number CNS disorders. The aim of these articles is to stimulate discussion on the question whether the immune system may be a feasible target of therapy for diseases where currently no effective treatment exists.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ascherio A, Munger KL (2007) Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 61:288–299
Gabibov AG, Belogurov AA Jr, Lomakin YA, Zakharova MY, Avakyan ME, Dubrovskaya VV, Smirnov IV, Ivanov AS, Molnar AA, Gurtsevitch VE, Diduk SV, Smirnova KV, Avalle B, Sharanova SN, Tramontano A, Friboulet A, Boyko AN, Ponomarenko NA, Tikunova NV (2011) Combinatorial antibody library from multiple sclerosis patients reveals antibodies that cross-react with myelin basic protein and EBV antigen. FASEB J 25:4211–4221
Lang HL, Jacobsen H, Ikemizu S, Andersson C, Harlos K, Madsen L, Hjorth P, Sondergaard L, Svejgaard A, Wucherpfennig K, Stuart DI, Bell JI, Jones EY, Fugger L (2002) A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol 3:940–943
Lunemann JD, Kamradt T, Martin R, Munz C (2007) Epstein-barr virus: environmental trigger of multiple sclerosis? J Virol 81:6777–6784
‘t Hart BA, Abbott DH, Nakamura K, Fuchs E (2012) The marmoset monkey: a multi-purpose preclinical and translational model of human biology and disease. Drug Discov Today 17(21–22):1160-1165
‘t Hart BA, Jagessar SA, Haanstra K, Verschoor E, Laman JD, Kap YS (2013) The primate EAE model points at EBV-infected B cells as a preferential therapy target in multiple sclerosis. Front Immunol in press
‘t Hart BA, Hintzen RQ, Laman JD (2009) Multiple sclerosis—a response-to-damage model. Trends Mol Med 15:235–244
Wilkin TJ (1990) The primary lesion theory of autoimmunity: a speculative hypothesis. Autoimmunity 7:225–235
Conflict of interest
The authors report no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
‘t Hart, B.A., den Dunnen, W.F. Commentary on Special Issue: CNS Diseases and the Immune System. J Neuroimmune Pharmacol 8, 757–759 (2013). https://doi.org/10.1007/s11481-013-9486-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11481-013-9486-0